Carr Financial Group Corp Vertex Pharmaceuticals Inc Transaction History
Carr Financial Group Corp
- $339 Billion
- Q2 2025
A detailed history of Carr Financial Group Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Carr Financial Group Corp holds 528 shares of VRTX stock, worth $197,714. This represents 0.07% of its overall portfolio holdings.
Number of Shares
528
Previous 608
13.16%
Holding current value
$197,714
Previous $295 Million
20.25%
% of portfolio
0.07%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,813Shares Held
232MCall Options Held
1.51MPut Options Held
1.09M-
Capital World Investors Los Angeles, CA28.5MShares$10.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$8.98 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.44 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.41 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $96.1B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...